| Views | |
|---|---|
| Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 73 |
| May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | |
|---|---|---|---|---|---|---|---|
| Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 2 | 1 | 1 | 10 | 3 | 4 | 0 |
| Views | |
|---|---|
| 2019_Ertaş_etal.pdf | 166 |
| 2019_Ertaş_etal.pdf | 6 |
